Nab-paclitaxel as First Line Treatment for NSCLC in Elderly Patients More Than 75 Years Old.
Zarogoulidis P, Huang H, Bai C, Petridis D, Papadopoulou S, Faniadou E, Eleftheriadou E, Trakada G, Cristoforos K, Rapti A, Yarmus L, Kopman DF, Man YG, Hohenforst-Schmidt W.
Zarogoulidis P, et al. Among authors: kopman df.
J Cancer. 2017 Jun 4;8(9):1673-1678. doi: 10.7150/jca.19463. eCollection 2017.
J Cancer. 2017.
PMID: 28775787
Free PMC article.